Hypertriglyceridemia and Alzheimer Disease: Opening the Mind to New Therapeutic Opportunities
Clin Chem
.
2021 Jan 8;67(1):6-8.
doi: 10.1093/clinchem/hvaa294.
Authors
Gerald F Watts
1
2
,
John C L Mamo
3
4
Affiliations
1
School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
2
Department of Cardiology, Lipid Disorders Clinic, Cardiometabolic Services, Royal Perth Hospital, Perth, Western Australia, Australia.
3
Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia, Australia.
4
School of Public Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
PMID:
33418571
DOI:
10.1093/clinchem/hvaa294
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Alzheimer Disease* / drug therapy
Cardiovascular Diseases*
Humans
Hypertriglyceridemia* / drug therapy
Risk Factors
Triglycerides
Substances
Triglycerides